The board of directors of Synmosa Biopharma Corporation approved the appropriations of earnings in cash dividends to shareholders of TWD 0.6 per share for the year ended December 31, 2022 and total amount of cash dividends to shareholders is TWD 196,285,035.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.55 TWD | +1.15% | +1.93% | +2.33% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.33% | 461M | |
+31.10% | 695B | |
+26.51% | 568B | |
-4.69% | 361B | |
+19.68% | 330B | |
+3.63% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+9.02% | 168B |
- Stock Market
- Equities
- 4114 Stock
- News Synmosa Biopharma Corporation
- Synmosa Biopharma Corporation Approves Dividend for the Year Ended December 31, 2022